{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:59:15Z","timestamp":1790085555994,"version":"4.0.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006683","name":"Xi'an Jiaotong-Liverpool University","doi-asserted-by":"publisher","award":["RDF-24-01-027"],"award-info":[{"award-number":["RDF-24-01-027"]}],"id":[{"id":"10.13039\/501100006683","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopha.2026.119865","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:17:52Z","timestamp":1787221072000},"page":"119865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluation of the immunomodulatory effects of novel phosphinic acid derivatives in vitro and in a murine colitis model"],"prefix":"10.1016","volume":"203","author":[{"given":"Xinhui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palmer","family":"Imbenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalini","family":"Matziari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyad","family":"Elkord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119865_bib1","unstructured":"GBD Results [dataset]. https:\/\/vizhub.healthdata.org\/gbd-results\/. (Accessed 27 March 2026)."},{"issue":"10","key":"10.1016\/j.biopha.2026.119865_bib2","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.dld.2023.04.003","article-title":"The global, regional, and national burden of inflammatory bowel diseases, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"55","author":"Park","year":"2023","journal-title":"Dig. Liver Dis."},{"issue":"13","key":"10.1016\/j.biopha.2026.119865_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137062","article-title":"Inflammatory Bowel Disease: a Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options","volume":"25","author":"Diez-Martin","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119865_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4137\/CGast.S12731","article-title":"Inflammatory bowel disease: an expanding global health problem","volume":"6","author":"Koma","year":"2013","journal-title":"Clin. Med. Insights Gastroenterol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119865_bib5","first-page":"13916","article-title":"Anti-TNF therapy and immunogenicity in inflammatory bowel diseases: a translational approach","volume":"13","author":"Genaro","year":"2021","journal-title":"Am. J. Transl. Res."},{"issue":"16","key":"10.1016\/j.biopha.2026.119865_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29163954","article-title":"Current Treatments, Emerging Therapeutics, and Natural Remedies for Inflammatory Bowel Disease","volume":"29","author":"Yeshi","year":"2024","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.biopha.2026.119865_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.25122\/jml-2018-0075","article-title":"A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease","volume":"12","author":"Seyedian","year":"2019","journal-title":"J. Med. Life"},{"issue":"7","key":"10.1016\/j.biopha.2026.119865_bib8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5694\/mja17.01001","article-title":"Management of inflammatory bowel disease","volume":"209","author":"Wright","year":"2018","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.biopha.2026.119865_bib9","doi-asserted-by":"crossref","first-page":"9987","DOI":"10.2147\/JIR.S492079","article-title":"Dissecting Innate and Adaptive Immunity in Inflammatory Bowel Disease: Immune Compartmentalization, Microbiota Crosstalk, and Emerging Therapies","volume":"17","author":"Yue","year":"2024","journal-title":"J. Inflamm. Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119865_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int. Immunol."},{"key":"10.1016\/j.biopha.2026.119865_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13020-020-0296-z","article-title":"Targeting NF-kappaB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines","volume":"15","author":"Lu","year":"2020","journal-title":"Chin. Med."},{"issue":"3","key":"10.1016\/j.biopha.2026.119865_bib12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cyto.2011.08.036","article-title":"TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation","volume":"56","author":"Olsen","year":"2011","journal-title":"Cytokine"},{"issue":"26","key":"10.1016\/j.biopha.2026.119865_bib13","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.3748\/wjg.v28.i26.3164","article-title":"Bifidobacterium infantis regulates the programmed cell death 1 pathway and immune response in mice with inflammatory bowel disease","volume":"28","author":"Zhou","year":"2022","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119865_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf160","article-title":"Modulating checkpoint molecules in inflammatory bowel diseases as a new therapeutic strategy: a narrative review","volume":"19","author":"Chkolnaia","year":"2025","journal-title":"J. Crohns Colitis"},{"issue":"1","key":"10.1016\/j.biopha.2026.119865_bib15","article-title":"PD-1-positive cells contribute to the diagnosis of inflammatory bowel disease and can aid in predicting response to vedolizumab","volume":"13","author":"Kim","year":"2023","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2026.119865_bib16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.celrep.2014.01.020","article-title":"Tissue-expressed B7-H1 critically controls intestinal inflammation","volume":"6","author":"Scandiuzzi","year":"2014","journal-title":"Cell. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2026.119865_bib17","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/s41385-019-0208-7","article-title":"Fine tuning of the DNAM-1\/TIGIT\/ligand axis in mucosal T cells and its dysregulation in pediatric inflammatory bowel diseases (IBD)","volume":"12","author":"Battella","year":"2019","journal-title":"Mucosal Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119865_bib18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.immuni.2018.07.007","article-title":"LAG3(+) Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1(+) Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis","volume":"49","author":"Bauche","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biopha.2026.119865_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00109-025-02631-z","article-title":"The role of the TIM-3 receptor in inflammatory bowel disease and autoimmunity: implications for TIM-3 and TCR crosstalk","volume":"104","author":"Gabel","year":"2026","journal-title":"J. Mol. Med. (Berl. )"},{"issue":"9","key":"10.1016\/j.biopha.2026.119865_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/jleuko\/qiaf116","article-title":"The function of metalloproteinases in pathophysiology of inflammatory bowel disease and colon cancer","volume":"117","author":"Manzanares","year":"2025","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119865_bib21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41420-024-02015-1","article-title":"Current understanding of the interplay between extracellular matrix remodelling and gut permeability in health and disease","volume":"10","author":"Vilardi","year":"2024","journal-title":"Cell. Death Discov."},{"issue":"14","key":"10.1016\/j.biopha.2026.119865_bib22","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/S0960-894X(03)00413-X","article-title":"Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3","volume":"13","author":"Reiter","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.biopha.2026.119865_bib23","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ijc.20459","article-title":"Dosing and scheduling influence the antitumor efficacy of a phosphinic peptide inhibitor of matrix metalloproteinases","volume":"113","author":"Dive","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2026.119865_bib24","doi-asserted-by":"crossref","first-page":"G175","DOI":"10.1152\/ajpgi.90454.2008","article-title":"Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis","volume":"296","author":"Garg","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119865_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/hep.21929","article-title":"Matrix metalloproteinase inhibition protects rat livers from prolonged cold ischemia-warm reperfusion injury","volume":"47","author":"Defamie","year":"2008","journal-title":"Hepatology"},{"issue":"40","key":"10.1016\/j.biopha.2026.119865_bib26","doi-asserted-by":"crossref","first-page":"41742","DOI":"10.1021\/acsomega.4c05988","article-title":"Symmetrical Phosphinic Acids: Synthesis and Esterification Optimization toward Potential HIV Prodrugs","volume":"9","author":"Hayat","year":"2024","journal-title":"Acs Omega"},{"issue":"50","key":"10.1016\/j.biopha.2026.119865_bib27","doi-asserted-by":"crossref","first-page":"62083","DOI":"10.1021\/acsomega.5c09361","article-title":"Highly Potent Phosphinic HIV\u20111 Protease Inhibitors: Synthesis, In Vitro Evaluation, and Docking Studies","volume":"10","author":"Hayat","year":"2025","journal-title":"Acs Omega"},{"issue":"12","key":"10.1016\/j.biopha.2026.119865_bib28","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1021\/acsptsci.2c00183","article-title":"Phosphinic Peptides as Tool Compounds for the Study of Pharmacologically Relevant Zn-Metalloproteases","volume":"5","author":"Georgiadis","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"43","key":"10.1016\/j.biopha.2026.119865_bib29","doi-asserted-by":"crossref","first-page":"25898","DOI":"10.1039\/D0RA04655H","article-title":"Phosphonopeptides containing free phosphonic groups: recent advances","volume":"10","author":"Kafarski","year":"2020","journal-title":"Rsc Adv."},{"key":"10.1016\/j.biopha.2026.119865_bib30","first-page":"1","article-title":"Phosphinic peptides as potent inhibitors of zinc-metalloproteases","volume":"360","author":"Georgiadis","year":"2015","journal-title":"Top. Curr. Chem."},{"issue":"49","key":"10.1016\/j.biopha.2026.119865_bib31","doi-asserted-by":"crossref","first-page":"19890","DOI":"10.1073\/pnas.1309781110","article-title":"Rationally designed inhibitor targeting antigen-trimming aminopeptidases enhances antigen presentation and cytotoxic T-cell responses","volume":"110","author":"Zervoudi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119865_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cellimm.2013.06.009","article-title":"Fosinoprilat alleviates lipopolysaccharide (LPS)-induced inflammation by inhibiting TLR4\/NF-kappaB signaling in monocytes","volume":"284","author":"Yang","year":"2013","journal-title":"Cell. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119865_bib33","article-title":"Effects of 1H-1,2,3-Triazole Derivatives of 3-O-Acetyl-11-Keto-Beta-Boswellic Acid from Boswellia sacra Resin on T-Cell Proliferation and Activation","volume":"17","author":"Meyiah","year":"2024","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.biopha.2026.119865_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110668","article-title":"Effect of Boswellic acids on T cell proliferation and activation","volume":"122","author":"Meyiah","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119865_bib35","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1007\/s10753-015-0180-7","article-title":"Sex Differences in Experimentally Induced Colitis in Mice: a Role for Estrogens","volume":"38","author":"Babickova","year":"2015","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.biopha.2026.119865_bib36","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.gastro.2006.12.028","article-title":"Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat","volume":"132","author":"Houdeau","year":"2007","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.biopha.2026.119865_bib37","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1093\/ibd\/izac094","article-title":"Sex-related Differences in Inflammatory Bowel Diseases: The Potential Role of Sex Hormones","volume":"28","author":"Xu","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"issue":"2","key":"10.1016\/j.biopha.2026.119865_bib38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/jpet.102.039529","article-title":"The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice","volume":"305","author":"Loher","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2026.119865_bib39","article-title":"Dihydroartemisinin Protects against Dextran Sulfate Sodium-Induced Colitis in Mice through Inhibiting the PI3K\/AKT and NF-kappaB Signaling Pathways","author":"Li","year":"2019","journal-title":"Biomed. Res. Int. 2019"},{"issue":"1","key":"10.1016\/j.biopha.2026.119865_bib40","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1038\/s41598-017-04041-9","article-title":"Uridine Ameliorates Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice","volume":"7","author":"Jeengar","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2026.119865_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042159","article-title":"The Anti-Inflammatory Effect of Acidic Mammalian Chitinase Inhibitor OAT-177 in DSS-Induced Mouse Model of Colitis","volume":"23","author":"Mazur","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119865_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/nu14051069","article-title":"Taxifolin Alleviates DSS-Induced Ulcerative Colitis by Acting on Gut Microbiome to Produce Butyric Acid","volume":"14","author":"Li","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2026.119865_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.119008","article-title":"Luteolin alleviates inflammation and modulates gut microbiota in ulcerative colitis rats","volume":"269","author":"Li","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2026.119865_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155941","article-title":"p-Hydroxy benzaldehyde, a phenolic compound from Nostoc commune, ameliorates DSS-induced colitis against oxidative stress via the Nrf2\/HO-1\/NQO-1\/NF-kappaB\/AP-1 pathway","volume":"133","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.biopha.2026.119865_bib45","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.drudis.2018.11.016","article-title":"Phosphinic acids: current status and potential for drug discovery","volume":"24","author":"Abdou","year":"2019","journal-title":"Drug. Discov. Today"},{"issue":"6","key":"10.1016\/j.biopha.2026.119865_bib46","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/0929867003374831","article-title":"Phosphinic acid compounds in biochemistry, biology and medicine","volume":"7","author":"Collinsova","year":"2000","journal-title":"Curr. Med. Chem."},{"issue":"10","key":"10.1016\/j.biopha.2026.119865_bib47","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1021\/jm401742r","article-title":"Synthesis and evaluation of phosphorus containing, specific CDK9\/CycT1 inhibitors","volume":"57","author":"Nemeth","year":"2014","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.biopha.2026.119865_bib48","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.1021\/jm500522y","article-title":"C-glycoside mimetics inhibit glioma stem cell proliferation, migration, and invasion","volume":"57","author":"Clarion","year":"2014","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119865_bib49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00384-024-04748-y","article-title":"Inflammatory bowel disease, colitis, and cancer: unmasking the chronic inflammation link","volume":"39","author":"Shahgoli","year":"2024","journal-title":"Int. J. Colorectal Dis."},{"issue":"10080","key":"10.1016\/j.biopha.2026.119865_bib50","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn's disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119865_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2025.1558092","article-title":"Visnagin treatment attenuates DSS-induced colitis by regulating inflammation, oxidative, stress, and mucosal damage","volume":"12","author":"Sravathi","year":"2025","journal-title":"Front. Vet. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119865_bib52","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/blood.V76.7.1392.1392","article-title":"Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes","volume":"76","author":"te Velde","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2026.119865_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.790658","article-title":"Immune Metabolism of IL-4-Activated B Cells and Th2 Cells in the Context of Allergic Diseases","volume":"12","author":"Lin","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119865_bib54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1471-230X-13-165","article-title":"Effects of interleukin-4 or interleukin-10 gene therapy on trinitrobenzenesulfonic acid-induced murine colitis","volume":"13","author":"Xiong","year":"2013","journal-title":"BMC Gastroenterol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119865_bib55","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.4049\/jimmunol.1001454","article-title":"Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production","volume":"186","author":"Feng","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2026.119865_bib56","article-title":"The role of Th17 cells in inflammatory bowel disease and the research progress","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119865_bib57","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/MIB.0000000000000714","article-title":"Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases","volume":"22","author":"Chen","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119865_bib58","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13063-019-3969-0","article-title":"Intravenous versus subcutaneous route pharmacokinetics of paracetamol (acetaminophen) in palliative care patients: study protocol for a randomized trial (ParaSCIVPallia)","volume":"21","author":"Vernant","year":"2020","journal-title":"Trials"},{"issue":"22","key":"10.1016\/j.biopha.2026.119865_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14227956","article-title":"Therapeutic Drug Monitoring in Special Circumstances in Inflammatory Bowel Disease","volume":"14","author":"Povlsen","year":"2025","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119865_bib60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11095-019-2745-x","article-title":"Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies?","volume":"37","author":"Al Shoyaib","year":"2019","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.biopha.2026.119865_bib61","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/jpp\/rgab118","article-title":"Pharmacokinetics, tissue distribution and peritoneal retention of Ag2S quantum dots following intraperitoneal administration to mice","volume":"73","author":"Mahlooji","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119865_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107095","article-title":"Small molecule drug absorption in inflammatory bowel disease and current implementation in physiologically- based pharmacokinetic models","volume":"209","author":"Langeraert","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119865_bib63","article-title":"Chemical- and Drug-Induced Allergic, Inflammatory, and Autoimmune Diseases Via Haptenation","volume":"12","author":"Sakamoto","year":"2023","journal-title":"Biol. (Basel)"},{"issue":"7","key":"10.1016\/j.biopha.2026.119865_bib64","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/nprot.2017.044","article-title":"Chemically induced mouse models of acute and chronic intestinal inflammation","volume":"12","author":"Wirtz","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2026.119865_bib65","article-title":"Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunity","author":"Erkes","year":"2014","journal-title":"J. Immunol. Res. 2014"},{"issue":"11","key":"10.1016\/j.biopha.2026.119865_bib66","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.4049\/jimmunol.1700209","article-title":"Definition of the Nature and Hapten Threshold of the beta-Lactam Antigen Required for T Cell Activation In Vitro and in Patients","volume":"198","author":"Meng","year":"2017","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119865_bib67","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/toxsci\/kfab144","article-title":"Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity","volume":"186","author":"Hammond","year":"2022","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.biopha.2026.119865_bib68","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.197126","article-title":"Epithelial SLPI Expression In Severe Inflammatory Bowel Disease Relates to High IL-17 and Neutrophil Programming","author":"Nugteren","year":"2026","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.biopha.2026.119865_bib69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00281-025-01062-9","article-title":"Crosstalk between the microbiota and intestinal dendritic cells in IBD","volume":"47","author":"Letz","year":"2025","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.biopha.2026.119865_bib70","article-title":"Neutrophils in inflammatory bowel disease: disease-promoting versus protective functions","volume":"16","author":"Yu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119865_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2026.124076","article-title":"Dual-functional tea polyphenol-serotonin nanoparticles for integrated inflammation suppression and mucosal repair in inflammatory bowel disease","volume":"331","author":"Tian","year":"2026","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.biopha.2026.119865_bib72","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1007\/s10787-024-01574-0","article-title":"Zhumeria majdae essential oil attenuates TNBS-induced colitis in rats by regulating inflammatory and apoptotic pathways","volume":"32","author":"Aghamiri","year":"2024","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2026.119865_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118768","article-title":"Combination of CBD with minor cannabinoid CBDV suppresses CXCR4 via CB2 receptor and alleviates colitis in mice","volume":"193","author":"Gelfand","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2026.119865_bib74","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2604908","article-title":"Crosstalk between the microbiota and intestinal gammadelta T cell compartments in health and IBD","volume":"18","author":"Parthasarathy","year":"2026","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biopha.2026.119865_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2026.118760","article-title":"Natural polyphenols in the treatment of IBD: pathological intervention activities and delivery system constructions","volume":"232","author":"Zhang","year":"2026","journal-title":"Food Res. Int."},{"issue":"5","key":"10.1016\/j.biopha.2026.119865_bib76","doi-asserted-by":"crossref","first-page":"G532","DOI":"10.1152\/ajpgi.00032.2025","article-title":"Regulatory T cells are induced by gut microbiota through differentially regulating costimulatory molecules of enteric glial cells","volume":"330","author":"Yang","year":"2026","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biopha.2026.119865_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109654","article-title":"Multi-omics integrative analysis elucidates the anti-inflammatory effects and underlying mechanisms of Arthrospira platensis-derived peptides in ulcerative colitis","volume":"173","author":"Yang","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2026.119865_bib78","doi-asserted-by":"crossref","DOI":"10.1093\/nutrit\/nuaf294","article-title":"Frontiers in gut health: the emerging role of berries in microbiota modulation and gastrointestinal diseases","author":"Guney-Coskun","year":"2026","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.biopha.2026.119865_bib79","article-title":"Dietary glyphosate at the regulatory \"Safe\" level worsens colitis via a gut microbiota-derived palmitic acid-JAK-STAT pathway","author":"Liu","year":"2026","journal-title":"J. Agric. Food Chem."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:59:31Z","timestamp":1790081971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226009017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":79,"alternative-id":["S0753332226009017"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119865","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the immunomodulatory effects of novel phosphinic acid derivatives in vitro and in a murine colitis model","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119865","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119865"}}